343 related articles for article (PubMed ID: 37762231)
1. The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells.
Bishayee K; Lee SH; Park YS
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762231
[TBL] [Abstract][Full Text] [Related]
2. The roles of glucose metabolic reprogramming in chemo- and radio-resistance.
Lin J; Xia L; Liang J; Han Y; Wang H; Oyang L; Tan S; Tian Y; Rao S; Chen X; Tang Y; Su M; Luo X; Wang Y; Wang H; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2019 May; 38(1):218. PubMed ID: 31122265
[TBL] [Abstract][Full Text] [Related]
3. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Fuel Dependence on Glutamine Drives Chemo-Resistance in the Cancer Stem Cells of Hepatocellular Carcinoma.
Lee ACK; Lau PM; Kwan YW; Kong SK
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805044
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW
Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560
[TBL] [Abstract][Full Text] [Related]
6. Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.
Azad AK; Lawen A; Keith JM
BMC Syst Biol; 2015 Jan; 9():2. PubMed ID: 25599599
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance.
Chen X; Chen S; Yu D
Metabolites; 2020 Jul; 10(7):. PubMed ID: 32708822
[TBL] [Abstract][Full Text] [Related]
8. Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells.
Nomura A; Dauer P; Gupta V; McGinn O; Arora N; Majumdar K; Uhlrich C; Dalluge J; Dudeja V; Saluja A; Banerjee S
Oncotarget; 2016 Aug; 7(35):56324-56337. PubMed ID: 27472388
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
You X; Jiang W; Lu W; Zhang H; Yu T; Tian J; Wen S; Garcia-Manero G; Huang P; Hu Y
Cancer Commun (Lond); 2019 Apr; 39(1):17. PubMed ID: 30947742
[TBL] [Abstract][Full Text] [Related]
10. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
Kim JJ; Rai R
Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
[TBL] [Abstract][Full Text] [Related]
11. Linking metabolic reprogramming to therapy resistance in cancer.
Morandi A; Indraccolo S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
[TBL] [Abstract][Full Text] [Related]
12. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
13. The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance.
Giacomini I; Ragazzi E; Pasut G; Montopoli M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023830
[TBL] [Abstract][Full Text] [Related]
14. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission.
Tyagi K; Mandal S; Roy A
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188563. PubMed ID: 33971276
[TBL] [Abstract][Full Text] [Related]
15. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
[TBL] [Abstract][Full Text] [Related]
16. [Cancer-associated gene abnormalities and chemosensitivity].
Sakamoto M; Umayahara K; Sakamoto H; Kawasaki K; Suehiro Y; Kunugi T; Akiya T; Iwabuchi H; Sakunaga H; Muroya T; Kikuchi Y; Sugishita T; Tenjin Y; Gray JW; Tanaka T
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1819-31. PubMed ID: 9797804
[TBL] [Abstract][Full Text] [Related]
17. IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.
Shigeta K; Hasegawa M; Hishiki T; Naito Y; Baba Y; Mikami S; Matsumoto K; Mizuno R; Miyajima A; Kikuchi E; Saya H; Kosaka T; Oya M
EMBO J; 2023 Feb; 42(4):e110620. PubMed ID: 36637036
[TBL] [Abstract][Full Text] [Related]
18. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells.
Dong Q; Zhou C; Ren H; Zhang Z; Cheng F; Xiong Z; Chen C; Yang J; Gao J; Zhang Y; Xu L; Fang J; Cao Y; Wei H; Wu Z
Cell Commun Signal; 2020 Oct; 18(1):167. PubMed ID: 33097055
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles derived from Lactobacillus plantarum restore chemosensitivity through the PDK2-mediated glucose metabolic pathway in 5-FU-resistant colorectal cancer cells.
An J; Ha EM
J Microbiol; 2022 Jul; 60(7):735-745. PubMed ID: 35781627
[TBL] [Abstract][Full Text] [Related]
20. Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics.
Salunkhe S; Mishra SV; Ghorai A; Hole A; Chandrani P; Dutt A; Chilakapati M; Dutt S
Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148300. PubMed ID: 32858000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
